BRONCHIECTASIS
Clinical trials for BRONCHIECTASIS explained in plain language.
Never miss a new study
Get alerted when new BRONCHIECTASIS trials appear
Sign up with your email to follow new studies for BRONCHIECTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for reducing dangerous lung flare-ups in bronchiectasis patients
Disease control CompletedThis study tested a drug called itepekimab in 312 adults with non-cystic fibrosis bronchiectasis, a lung condition that causes chronic cough and infections. The goal was to see if it can reduce the number of moderate or severe lung infections (called exacerbations) over up to a y…
Matched conditions: BRONCHIECTASIS
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 26, 2026 05:53 UTC
-
New pill aims to tame lung damage in cystic fibrosis
Disease control CompletedThis study tested a new tablet called BI 1291583 in 22 adults with cystic fibrosis and bronchiectasis (damaged airways). Participants took either the study drug or a placebo once daily for 12 weeks. The main goal was to see if the drug is safe and tolerable, and to measure its ef…
Matched conditions: BRONCHIECTASIS
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 26, 2026 05:41 UTC
-
New pain block technique may reduce opioid use after chest surgery
Symptom relief CompletedThis study tested two types of nerve blocks to control pain after chest surgery (thoracotomy) in 180 adults. One method is a standard paravertebral block, and the other is a newer, potentially safer mid-point block. The goal was to see if the newer block provides similar pain rel…
Matched conditions: BRONCHIECTASIS
Phase: NA • Sponsor: Fayoum University Hospital • Aim: Symptom relief
Last updated May 26, 2026 05:54 UTC
-
New airway device aims to keep patients breathing easier during lung scope
Symptom relief CompletedThis study tested a new device called the COMBO Endoscopy Oropharyngeal Airway in 104 adults having a lung scope procedure under sedation. The device combines oxygen support, breathing monitoring, and a bite block to prevent low oxygen levels. The goal was to see if it reduces th…
Matched conditions: BRONCHIECTASIS
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Symptom relief
Last updated May 26, 2026 05:53 UTC